Jennifer Lew
Director of Finance/CFO bij ANNEXON, INC.
Vermogen: 588 356 $ op 31-03-2024
Profiel
Jennifer Lew is currently an Independent Director at Boundless Bio, Inc. and the Chief Financial Officer & Executive Vice President at Annexon, Inc. She previously worked as a Finance Director & Assistant Controller at QRS Corp.
from 2000 to 2004, an Audit Manager at Ernst & Young LLP from 1994 to 1999, the VP, Chief Financial & Accounting Officer at Dynavax Technologies Corp.
in 2013, and the Chief Financial & Accounting Officer at Aduro BioTech, Inc. from 2013 to 2019.
Ms. Lew obtained her undergraduate degree from Claremont McKenna College in 1994.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ANNEXON, INC.
0.09% | 20-02-2024 | 82 058 ( 0.09% ) | 588 356 $ | 31-03-2024 |
BOUNDLESS BIO INC.
-.--% | 28-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Jennifer Lew
Bedrijven | Functie | Begin |
---|---|---|
ANNEXON, INC. | Director of Finance/CFO | 01-06-2019 |
BOUNDLESS BIO, INC. | Director/Board Member | 05-01-2022 |
Eerdere bekende functies van Jennifer Lew
Bedrijven | Functie | Einde |
---|---|---|
CHINOOK THERAPEUTICS, INC. | Director of Finance/CFO | 24-05-2019 |
DYNAVAX TECHNOLOGIES CORPORATION | Director of Finance/CFO | 15-10-2013 |
QRS Corp.
QRS Corp. Internet Software/ServicesTechnology Services QRS Corp. provide electronic commerce merchandising and logistics solutions. The services include catalog services, network services, inventory management services, logistics management services and professional services. The company is headquartered in Richmond, CA. | Director of Finance/CFO | 01-01-2004 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01-01-1999 |
Opleiding van Jennifer Lew
Claremont McKenna College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
ANNEXON, INC. | Health Technology |
BOUNDLESS BIO, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
QRS Corp.
QRS Corp. Internet Software/ServicesTechnology Services QRS Corp. provide electronic commerce merchandising and logistics solutions. The services include catalog services, network services, inventory management services, logistics management services and professional services. The company is headquartered in Richmond, CA. | Technology Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |